2005
DOI: 10.1016/s1579-2129(06)60247-4
|View full text |Cite
|
Sign up to set email alerts
|

Endothelial Dysfunction in Pulmonary Hypertension

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2024
2024
2024
2024

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 27 publications
0
1
0
Order By: Relevance
“…This finding coincides with our experimental results. Endothelial dysfunction occurs in the early stages of PH and is reflected by reduction in the secretion of vasodilators, such as NO and prostacyclin, and overproduction of vasoconstrictive factors, such as ET-1 and thromboxane [ 33 ]. Reduced generation of NO, due to reduced synthesis of eNOS in ECs, attenuates its protective effect against PH, including vasodilation and inhibition of proliferation of pulmonary SMCs [ 9 , 10 ].…”
Section: Discussionmentioning
confidence: 99%
“…This finding coincides with our experimental results. Endothelial dysfunction occurs in the early stages of PH and is reflected by reduction in the secretion of vasodilators, such as NO and prostacyclin, and overproduction of vasoconstrictive factors, such as ET-1 and thromboxane [ 33 ]. Reduced generation of NO, due to reduced synthesis of eNOS in ECs, attenuates its protective effect against PH, including vasodilation and inhibition of proliferation of pulmonary SMCs [ 9 , 10 ].…”
Section: Discussionmentioning
confidence: 99%